Physiomics Company
Physiomics is a leading oncology drug development consultancy using proprietary state of the artVirtual Tumour™ technology and other tools to predict and better understand the effects of cancer treatments. We work with partners developing cancer drugs to help them save time and money during pre-clinical and clinical development.
Employee Number:
1-10
Funding Status:
IPO
Headquarters:
Oxford, Oxfordshire, United Kingdom
Technology:
Medical Devices
Founded Date:
2002
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A
Industry:
PharmTech